T1	Participants 628 731	The study group had 12,855 patients, of whom 7,967 (62.0%) were treated preoperatively with β-blockers.
T2	Participants 95 238	Since 2007, the use of preoperative β-blockers has been used as a quality standard for patients undergoing coronary artery bypass graft surgery
